UNSPSC 41141968: Galactose test system

In this classification, Galactose test system connotes a device used to measure Galactose levels. US FDA regulates Galactose test system under 21 CFR 862.1310 and under FDA product code JIA.

UNSPSC 41141968 Galactose test system, Commodity, encompasses forensic drug testing reagents, reference materials, and related laboratory supplies used by state public safety, health, and law enforcement agencies to conduct substance analysis and method validation in crime laboratories. The code captures immunoassay kits for direct ELISA screening of controlled substances (cannabinoids, opiates, amphetamines, benzodiazepines, oxycodone, and related compounds), certified reference drug standards meeting ISO/IEC 17025 accreditation standards, and ancillary testing materials such as phosphate-buffered saline solution. The issuing bodies are predominantly state-level departments—the Texas Department of Public Safety, Texas Health and Human Services Commission, and Florida Department of Law Enforcement—alongside county forensic laboratories (Pinellas County, Florida). The work is purely transactional procurement of commercial consumables and reagents rather than development or services.

Recent activity concentrates in Texas and Florida. The Texas Department of Public Safety issued IFB 405-26R0008445A on July 9, 2026, for immunoanalysis reagent kits with a response deadline of July 23, 2026, under a sole-source procurement methodology. The Pinellas County Forensic Laboratory (in partnership with FDLE) released ITQ 26-0305-ITQ on April 23, 2026, for 131 line items of certified drug reference standards with delivery by June 1, 2026, under a federal Paul Coverdell grant with approximately $49,034 allocated to supplies and equipment. The Texas Health and Human Services Commission solicited QIAxcel and QIAamp DNA screening kits through IFB HHS0016902v2 with a January 29, 2026, deadline and estimated annual value between $25,050 and $30,000, though this opportunity reflects DNA screening rather than drug testing specificity. Illinois issued a sole-source notice of intent in May 2026 for the RAMP mosquito-borne illness testing system, indicating broader government laboratory standardization patterns. Set-asides appear in Florida (SBE preference with five-percent price advantage for early-bid SBEs) and Texas (HUB subcontracting plan encouraged but not required for HHSC). Response cycles are tight—most solicitations cluster between seven and fourteen days—and contract terms run twelve months with optional renewals tied to funding availability.